Marlen Metzner
7PUBLICATIONS
52CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 05, 2025
Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy.Sven Turkalj, Felix A Radtke, Bilyana Stoilova
|Jun 25, 2025
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome.Natalina Elliott, Neha Bhatnagar, Gemma Buck
|Nov 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial.Nigel H Russell, Abin Thomas, Robert K Hills
|Sep 04, 2024
Risk Stratification in Older Intensively Treated Patients With AML.Jurjen Versluis, Marlen Metzner, Ariel Wang
|Aug 23, 2024
Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved.Merve Aksöz, Grigore-Aristide Gafencu, Bilyana Stoilova
|Aug 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial.Sylvie D Freeman, Abin Thomas, Ian Thomas
Pageof 2
Frequent Collaborators
7 joint publications
Paresh Vyas
4 joint publications
Niels Asger Jakobsen
3 joint publications
Steven Knapper
3 joint publications
Bilyana Stoilova
3 joint publications
Sylvie D Freeman
3 joint publications
Abin Thomas
2 joint publications
Amanda Gilkes
2 joint publications
Nigel Russell
2 joint publications
Priyanka Mehta
2 joint publications
Alison Kennedy
